Published in Cancer Weekly, June 15th, 2004
"A new controlled drug delivery system for selective chemotherapy was developed," scientists writing in the journal Bioorganic & Medicinal Chemistry report.
"It is based on a chemical adaptor unit that releases a drug by a spontaneous cyclization mechanism after cleavage of an enzymatic substrate. It also provides a generic linkage of a drug with a targeting device in a manner set to be triggered by defined enzymatic activity," wrote A. Gopin and colleagues, Tel Aviv University.
"The system is generic and allows using a variety of drugs, targeting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.